Lab Manager speaks to Dan O’Connor, vice president, drug discovery, Molecular Devices, about the company’s Organoid Innovation Center in San Jose, CA. The center is 180 sq. ft., within a larger wet lab area measuring 1,440 sq. ft., and was completed in April 2021.
Q: What was the need for this facility? Is it replacing an outdated existing facility or accommodating new research/ a new program?
A: Molecular Devices successfully partners with customers to advance their 3D biology research by incorporating laboratory systems that automate and scale organoid workflows. This approach of designing a fully integrated, end-to-end solution—which encompasses organoid development through to high-content imaging and screening—has answered challenges our customers routinely experience when moving to 3D biology.